Home › Stocks › MED › All Fund Holders
MED — MEDIFAST INC · All Fund Holders
Funds holding (latest): 44 · Reported value held: $63.19M
| Fund | Quarter | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|---|
| Renaissance Technologies history | Q2 2026 | 778.61K | $8.26M | 0.01% | Add |
| Vanguard Group history | Q4 2025 | 711.50K | $7.60M | 0.00% | Hold |
| Two Sigma Investments history | Q2 2026 | 481.38K | $5.11M | 0.00% | Add |
| Norges Bank Investment Management history | Q4 2023 | 71.06K | $4.78M | 0.00% | Reduce |
| Charles Schwab Investment Management history | Q2 2026 | 397.00K | $4.21M | 0.00% | Reduce |
| BlackRock Inc history | Q2 2026 | 369.50K | $3.92M | 0.00% | Reduce |
| Citadel Advisors history | Q2 2026 | 355.35K | $3.77M | 0.00% | Reduce |
| Morgan Stanley history | Q2 2026 | 292.51K | $3.10M | 0.00% | Reduce |
| Wellington Management Group history | Q2 2023 | 31.51K | $2.90M | 0.00% | Reduce |
| Goldman Sachs Group history | Q2 2026 | 243.09K | $2.58M | 0.00% | Add |
| Marshall Wace history | Q2 2026 | 241.65K | $2.56M | 0.00% | New |
| AQR Capital Management history | Q2 2026 | 236.43K | $2.51M | 0.00% | Add |
| Geode Capital Management history | Q2 2026 | 121.07K | $1.29M | 0.00% | Reduce |
| JPMorgan Chase & Co history | Q2 2026 | 92.51K | $989.88K | 0.00% | New |
| D. E. Shaw & Co history | Q2 2026 | 92.34K | $979.78K | 0.00% | Reduce |
| Bank of America Corp history | Q2 2026 | 87.12K | $924.32K | 0.00% | Reduce |
| Arrowstreet Capital history | Q4 2024 | 51.40K | $905.60K | 0.00% | Reduce |
| PSP Investments history | Q1 2024 | 22.61K | $866.30K | 0.01% | Hold |
| Bridgewater Associates history | Q1 2024 | 17.46K | $669.11K | 0.00% | Reduce |
| Royce & Associates history | Q3 2023 | 8.46K | $633.38K | 0.01% | New |
| UBS Group AG history | Q2 2026 | 50.22K | $532.87K | 0.00% | Add |
| Millennium Management history | Q2 2026 | 47.91K | $508.28K | 0.00% | New |
| Amundi US history | Q2 2025 | 30.44K | $445.02K | 0.00% | Hold |
| Manulife Financial history | Q4 2023 | 5.26K | $353.85K | 0.00% | Reduce |
| Franklin Resources history | Q1 2024 | 9.14K | $350.25K | 0.00% | Add |
| BNY Mellon history | Q1 2026 | 34.29K | $349.43K | 0.00% | Reduce |
| MFS Investment Management history | Q4 2023 | 4.38K | $294.69K | 0.00% | New |
| Northern Trust Corp history | Q2 2026 | 27.76K | $294.49K | 0.00% | Reduce |
| CPP Investments history | Q3 2024 | 13.10K | $250.73K | 0.00% | Hold |
| Principal Global Investors history | Q2 2024 | 10.23K | $223.22K | 0.00% | Reduce |
| Point72 Asset Management history | Q2 2026 | 21.00K | $222.80K | 0.00% | New |
| Janus Henderson Group history | Q1 2024 | 5.36K | $205.37K | 0.00% | Reduce |
| Prudential Financial history | Q2 2025 | 14.21K | $199.59K | 0.00% | New |
| Invesco Ltd history | Q2 2026 | 13.31K | $141.27K | 0.00% | Reduce |
| Deutsche Bank AG history | Q1 2026 | 8.62K | $87.89K | 0.00% | Hold |
| Balyasny Asset Management history | Q4 2022 | 369 | $42.56K | 0.00% | Reduce |
| Citigroup Inc history | Q1 2026 | 3.60K | $36.67K | 0.00% | Reduce |
| Fidelity Management & Research (FMR) history | Q2 2026 | 2.73K | $28.97K | 0.00% | Add |
| Wells Fargo & Co history | Q2 2026 | 2.22K | $23.52K | 0.00% | Reduce |
| Baillie Gifford & Co history | Q1 2023 | 154 | $15.96K | 0.00% | Add |
| PNC Financial Services history | Q2 2026 | 1.39K | $14.71K | 0.00% | Add |
| Legal & General Investment Management America history | Q1 2026 | 929 | $9.47K | 0.00% | Hold |
| T. Rowe Price Associates history | Q2 2026 | 32.38K | $344 | 0.00% | Add |
| Lazard Asset Management history | Q4 2023 | 205 | $13 | 0.00% | Reduce |